KAZIA THERAPEUTICS LTD (KZIA) AI Dilution Summary

Estimated cash was $107,340,803 as of 2026-08-31, rolled forward from $69,459,980 at 2025-12-31 against estimated monthly burn of $1,590,104. The company funds itself through an active ATM program with Leerink Partners LLC authorised to $80,000,000, and most recently raised $37,190,669.68 net in an underwritten public offering dated 2026-08-31. Dilution here is driven primarily by that $80,000,000 ATM.